Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006;8(1):201.
doi: 10.1186/ar1857. Epub 2005 Nov 29.

Osteoclasts; culprits in inflammatory osteolysis

Affiliations
Review

Osteoclasts; culprits in inflammatory osteolysis

Steven L Teitelbaum. Arthritis Res Ther. 2006.

Abstract

Periarticular osteolysis, a crippling complication of rheumatoid arthritis, is the product of enhanced osteoclast recruitment and activation. The osteoclast, which is a member of the monocyte/macrophage family, is the exclusive bone resorptive cell, and its differentiation and activation are under the aegis of a variety of cytokines. Receptor activator of NF-kappaB ligand (RANKL) and macrophage colony-stimulating factor are the essential osteoclastogenic cytokines and are increased in inflammatory joint disease. Tumor necrosis factor-alpha, which perpetrates arthritic bone loss, exerts its osteoclastogenic effect in the context of RANKL with which it synergizes. Achieving an understanding of the mechanisms by which the three cytokines affect the osteoclast has resulted in a number of active and candidate therapeutic targets.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The osteoclast's bone resorptive cycle. (a) The osteoclast, when unattached to bone, is a non-polarized polykaryon with fibrillar actin (red material) diffusely distributed throughout the cell. (b) Upon attachment to bone the actin cytoskeleton forms a ring, or sealing zone, which isolates the resorptive microenvironment from the general extracellular space. (c) At the same time, acidifying vesicles polarize and insert into the plasma membrane juxtaposed to bone to generate the cell's resorptive organelle, the ruffled membrane. (d) The polarized osteoclast secretes hydrochloric acid (HCL), which acidifies the resorptive microenvironment, leading to mobilization of the mineral phase of bone. The exposed organic matrix is then degraded by cathepsin K (Cath K). Having resorbed the underlying bone to a depth of about 50 μm, the osteoclast detaches, disassembles its actin ring and ruffled membrane, and migrates to its next site of resorption.
Figure 2
Figure 2
Mechanisms of osteoclastogenesis induced by tumour necrosis factor (TNF)-α/IL-1. TNF-α interacts with its p55 receptor (TNFR) on both marrow stromal cells and osteoclast precursors in the form of marrow macrophages. Activation of the TNFR stimulates the expression of macrophage colony-stimulating factor (M-CSF) by stromal cells, which occupies its receptor, c-Fms, on osteoclast precursors. Signaling through p38 mitogen-activated protein kinase, TNF-α also induces stromal-cell synthesis of IL-1, which upregulates its own functional receptor, IL-1RI. Occupancy of now abundant IL-1RI similarly activates p38, which promotes RANKL production. In macrophages, TNF-α enhances RANK expression and the synthesis of IL-1, whose functional receptor is upregulated by the same three cytokines, also in a p38-dependent manner. Coincidentally, RANKL suppresses the IL-1 decoy receptor IL-1RII. TNF-α-induced IL-1RI upregulation in macrophages occurs by a combination of IL-1-dependent and IL-1-independent mechanisms. IL-1 interacting with its receptor on osteoclast precursors, in conjunction with RANKL and M-CSF, directly induces these cells to commit to the osteoclast phenotype. IL-1 mediates about 50% of the osteoclastogenic effect of TNF-α. (Modified from [80].)

Similar articles

Cited by

References

    1. Smolen JS, Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov. 2003;2:473–488. doi: 10.1038/nrd1109. - DOI - PubMed
    1. Scott DL, Pugner K, Kaarela K, Doyle DV, Woolf A, Holmes J, Hieke K. The links between joint damage and disability in rheumatoid arthritis. Rheumatology. 2000;39:122–132. doi: 10.1093/rheumatology/39.2.122. - DOI - PubMed
    1. Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM. Mechanisms of TNF-α- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest. 2003;111:821–831. doi: 10.1172/JCI200316069. - DOI - PMC - PubMed
    1. Goldring SR, Clark CR, Wright TM. The problem in total joint arthroplasty: aseptic loosening. Journal of Bone & Joint Surgery – American Volume. 1993;75:799–801. - PubMed
    1. Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med. 2004;351:2839–2849. doi: 10.1056/NEJMra040952. - DOI - PubMed